US20080026976A1 - Highly productive alpha-amylases - Google Patents
Highly productive alpha-amylases Download PDFInfo
- Publication number
- US20080026976A1 US20080026976A1 US11/590,769 US59076906A US2008026976A1 US 20080026976 A1 US20080026976 A1 US 20080026976A1 US 59076906 A US59076906 A US 59076906A US 2008026976 A1 US2008026976 A1 US 2008026976A1
- Authority
- US
- United States
- Prior art keywords
- amino acid
- acid residue
- residue corresponding
- amylase
- glu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000637 alpha-Amylases Proteins 0.000 title claims abstract description 91
- 102000004139 alpha-Amylases Human genes 0.000 title claims abstract description 83
- 125000000539 amino acid group Chemical group 0.000 claims description 73
- 229940024171 alpha-amylase Drugs 0.000 claims description 50
- 108090000623 proteins and genes Proteins 0.000 claims description 43
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 33
- 239000003599 detergent Substances 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 15
- 238000006467 substitution reaction Methods 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 238000012217 deletion Methods 0.000 claims description 8
- 230000037430 deletion Effects 0.000 claims description 8
- 239000013598 vector Substances 0.000 claims description 4
- 244000005700 microbiome Species 0.000 abstract description 10
- 102000004190 Enzymes Human genes 0.000 description 90
- 108090000790 Enzymes Proteins 0.000 description 90
- 229940088598 enzyme Drugs 0.000 description 90
- 102000013142 Amylases Human genes 0.000 description 42
- 108010065511 Amylases Proteins 0.000 description 42
- 230000035772 mutation Effects 0.000 description 36
- 239000004382 Amylase Substances 0.000 description 34
- 235000019418 amylase Nutrition 0.000 description 34
- 238000000034 method Methods 0.000 description 28
- 230000000694 effects Effects 0.000 description 21
- 239000013612 plasmid Substances 0.000 description 20
- 239000012634 fragment Substances 0.000 description 15
- 239000002609 medium Substances 0.000 description 15
- 239000013615 primer Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 12
- 239000006228 supernatant Substances 0.000 description 12
- 229920002472 Starch Polymers 0.000 description 11
- -1 lypase Proteins 0.000 description 11
- 239000007800 oxidant agent Substances 0.000 description 11
- 230000001590 oxidative effect Effects 0.000 description 11
- 235000019698 starch Nutrition 0.000 description 11
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- 244000063299 Bacillus subtilis Species 0.000 description 8
- 235000014469 Bacillus subtilis Nutrition 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 238000002741 site-directed mutagenesis Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000002703 mutagenesis Methods 0.000 description 5
- 231100000350 mutagenesis Toxicity 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 102220137697 rs149964046 Human genes 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 231100000219 mutagenic Toxicity 0.000 description 4
- 230000003505 mutagenic effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- LWFUFLREGJMOIZ-UHFFFAOYSA-N 3,5-dinitrosalicylic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O LWFUFLREGJMOIZ-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 108010028688 Isoamylase Proteins 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 229910002651 NO3 Inorganic materials 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 108010035855 neopullulanase Proteins 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 102200110015 rs3087373 Human genes 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- 101710166469 Endoglucanase Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 102100022624 Glucoamylase Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- OCIBBXPLUVYKCH-QXVNYKTNSA-N alpha-maltohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-QXVNYKTNSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102220006254 rs267606667 Human genes 0.000 description 2
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 239000006171 Britton–Robinson buffer Substances 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- WQZGKKKJIJFFOK-DHVFOXMCSA-N L-galactose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-DHVFOXMCSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- RLZLDSDDRORMOV-DBQHITQZSA-M [Na+].Cl.COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O.CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC Chemical compound [Na+].Cl.COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O.CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC RLZLDSDDRORMOV-DBQHITQZSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000009990 desizing Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 101150087199 leuA gene Proteins 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- DJMVHSOAUQHPSN-UHFFFAOYSA-N malto-hexaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(O)C(CO)O4)O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 DJMVHSOAUQHPSN-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 1
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 1
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 108010087558 pectate lyase Proteins 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 108010070456 protopectinase Proteins 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000344 soap Chemical class 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000007921 solubility assay Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009633 stab culture Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
Definitions
- the present invention relates to mutant ⁇ -amylases having improved productivity.
- ⁇ -Amylases [EC.3.2.1.1.] have been used in a wide range of industrial fields such as starch industry, brewing industry, fiber industry, pharmaceutical industry and food industry. Among them, those capable of degrading starches at high random are suited for detergents. Conventionally known as such are, as well as ⁇ -amylases derived from Bacillus licheniformis , liquefying alkaline ⁇ -amylases derived from the alkaliphilic strain Bacillus sp. KSM-AP1378 (FERM BP-3048) (WO94/26881) and improved enzymes having improved heat resistance and oxidant resistance (WO98/44126).
- the present inventors have recently found liquefying alkaline ⁇ -amylases derived from the alkaliphilic strain Bacillus sp. KSM-K38 (FERM BP-6946) and having chelating-agent- and oxidation-resistance (Japanese Patent Application No. Hei 10-362487, Japanese Patent Application No. Hei 10-362488); and improved enzymes having improved heat resistance (Japanese Patent Application No. Hei 11-163569).
- enzymes for detergents are required to have high productivity in consideration of their industrial production.
- various trials have been made to improve the heat resistance or oxidant resistance of ⁇ -amylases for detergent by using protein engineering technique, neither improvement of productivity has been considered sufficiently nor an attempt of production increase by mutation of a structural gene has been reported yet.
- An object of the present invention is to provide mutant ⁇ -amylases having excellent productivity.
- the present inventors introduced, in microorganisms, mutant ⁇ -amylase structural gene constructed by site-directed mutagenesis and evaluated productivity of ⁇ -amylases. As a result, it has been found that since an ( ⁇ -amylase gene has a site taking part in the improvement of productivity, introduction, into a microorganism, of a recombinant gene having this site mutated makes it possible to produce ⁇ -amylases having drastically improved productivity.
- a mutant ⁇ -amylase which is derived from an ⁇ -amylase having an amino acid sequence represented by SEQ ID No. 1 or showing at least 60% homology thereto by substitution or deletion of at least one amino acid residue corresponding to any one of Pro 19 , Gln 86 , Glu 130 , Asn 154 , Arg 171 , Ala 186 , Glu 212 , Val 222 , Tyr 243 , Pro 260 , Lys 269 , Glu 276 , Asn 277 , Arg 310 , Glu 360 , Gln 391 , Trp 439 , Lys 444 , Asn 471 and Gly 476 of the amino acid sequence.
- a mutant ⁇ -amylase derived from an ⁇ -amylase having an amino acid sequence represented by SEQ ID No. 2 or showing at least 60% homology thereto by substitution or deletion of at least one amino acid residue corresponding to any one of Asp 128 , Gly 140 , Ser 144 , Arg 168 , Asn 181 , Glu 207 , Phe 272 , Ser 375 , Trp 434 and Glu 466 of the amino acid sequence.
- a gene encoding this mutant ⁇ -amylase a vector containing the gene, a cell transformed with the vector and a production method of a mutant ⁇ -amylase which comprises cultivating the transformed cell.
- FIG. 1 illustrates a method of constructing a recombinant plasmid for production of an ⁇ -amylase derived from the strain KSM-1378 or KSM-K38.
- FIG. 2 is a schematic view illustrating a method of introducing a mutation into an ⁇ -amylase gene derived from the strain KSM-1378 or KSM-K38.
- highly productive mutant ⁇ -amylase as used herein means an ⁇ -amylase whose yield is increased, upon production of it by cultivating a recombinant microorganism, by at least 5%, preferably at least 10%, more preferably at least 20% compared with that before mutation.
- the mutant ⁇ -amylase of the present invention is constructed so that out of amino acids constituting the ⁇ -amylase, the amino acid residues taking part in the productivity are substituted with another amino acid residues or deleted.
- the ⁇ -amylase usable here include liquefying ⁇ -amylases derived from Bacillus. amyloliquefaciens or Bacillus. licheniformis and liquefying alkaline ⁇ -amylases derived from alkaliphilic microorganisms belonging to the Bacillus sp., of which ⁇ -anylases having an amino acid sequence represented by SEQ ID No. 1 or SEQ ID No. 2 and ⁇ -amylases having at least 60% homology to the above-described amino acid sequence are preferred.
- Examples of the ⁇ -amylase having the amino acid sequence represented by SEQ ID No. 1 or ⁇ -amylase having at least 60% homology thereto include liquefying alkaline ⁇ -amylases derived from the strain Bacillus sp. KSM-AP1378 (FERM BP-3048) (Japanese Patent Application Laid-Open No. Hei 8-336392) and improved enzymes of the above-described one in heat resistance and oxidant resistance which are constructed by protein engineering technique (WO98/44126).
- Examples of the ⁇ -amylase having the amino acid sequence represented by SEQ ID No. 2 or having at least 60% is homology thereto include liquefying alkaline ⁇ -amylases derived from the strain Bacillus sp. KSM-K38 (FERM BP-6946) and improved enzymes of the above-described one in heat resistance which are constructed by protein engineering technique (Japanese Patent Application No. Hei 11-163569).
- the homology of an amino acid sequence is calculated by Lipman-Pearson method (Science, 227, 1435(1985)).
- the mutant ⁇ -amylase of the present invention can be obtained first by cloning, from a microorganism producing an ⁇ -amylase, a gene encoding the ⁇ -amylase.
- a gene encoding the ⁇ -amylase ordinarily employed gene recombinant technique, for example, the method as described in Japanese Patent Application Laid-Open No. Hei 8-336392 may be employed.
- Examples of the gene usable here include that represented by SEQ ID No. 3 or SEQ ID No. 4 which encodes the amino acid sequence represented by SEQ ID No. 1 or SEQ ID No. 2.
- Mutant genes derived from the above-described ones and having improved heat resistance and oxidant resistance are also usable.
- any site-directed mutagenesis ordinarily employed can be adopted.
- mutation can be conducted using a “Site-Directed Mutagenesis System Mutan-Super Express Km” kit (product of Takara Shuzo Co., Ltd.).
- Mutation for obtaining highly productive ⁇ -amylases of the invention can be attained, for example, by substitution or deletion, in an ⁇ -amylase having an amino acid sequence represented by SEQ ID No. 1 or having at least 60% homology thereto, of at least one amino acid residue corresponding to any one of Pro 18 , Gln 86 , Glu 130 , Asn 154 , Arg 171 , Ala 186 , Glu 212 , Val 222 , Tyr 243 , Pro 260 , Lys 269 , Glu 276 , Asn 277 , Arg 310 , Glu 360 , Gln 391 , Trp 439 , Lys 444 , Asn 471 and Gly 476 of the amino acid sequence; or by substitution or deletion, in another ⁇ -amylase having an amino acid sequence represented by SEQ ID No.
- Preferred mutations include, in the amino acid sequence of SEQ ID No.
- amino acid sequence of SEQ ID No. 2 of the amino acid residue corresponding to ASP128 with Val or Gln, the amino acid residue corresponding to Gly 140 with Ser, the amino acid residue corresponding to Ser 144 with Pro, the amino acid residue corresponding to Arg 168 with Gln, the amino acid residue corresponding to Gln 181 with Val, the amino acid residue corresponding to Glu 270 with Asp, the amino acid residue corresponding to Phe 272 with Ser, the amino acid residue corresponding to Ser 375 with Pro, the amino acid residue corresponding to Trp 434 with Arg or the amino acid residue corresponding to Glu 466 with Asp.
- mutations of the amino acid sequence of SEQ ID No. 1 those by substitution of the amino acid residue corresponding to Gln86 with Glu, the amino acid residue corresponding to Glu 130 with Val or Gln, the amino acid residue corresponding to Ala 186 with Asn, the amino acid residue corresponding to Tyr 243 with Ser, the amino acid residue corresponding to Pro 260 with Glu, the amino acid residue corresponding to Lys 269 with Gln, the amino acid residue corresponding to Asn 277 with Phe and the amino acid residue corresponding to Asn 471 with Asp or Glu can bring about improvement in solubility of the ⁇ -amylase in a culture medium or desalted and concentrated solution thereof.
- the above-described mutations make it possible to improve the residual activity of the ⁇ -amylase in the supernatant after storage at 4° C. for one week in a desalted and concentrated solution by at least 5%, especially 10% compared with the activity before mutation. Accordingly, in the case of the mutant ⁇ -amylases of the present invention obtained by such amino acid mutations, a fermented concentrate solution of a high concentration is available at a high yield and enzyme formulation treatment such as ultrafiltration after fermentation production can be conducted efficiently.
- a combination of two or more substitutions or deletions of various amino acid residues is also effective for such amino acid mutations. It is also possible to use the above-exemplified mutation in combination with a mutation for improving enzymatic properties, for example, in an ⁇ -amylase having an amino acid sequence represented by SEQ ID No. 1 or having at least 60% homology thereto, a mutation for improving heat resistance by deleting amino acid residues corresponding to Arg 181 , and Gly 182 , a mutation for improving oxidant resistance by substituting the amino acid residue corresponding to Met 222 with Thr or a mutation for improving solubility by substituting the amino acid residue corresponding Lys 484 with Gln; or in an ⁇ -amylase having an amino acid sequence represented by SEQ ID No.
- a mutant ⁇ -amylase is available at a high yield by appropriately combining a mutant ⁇ -amylase structural gene with a control gene and a proper plasmid vector, thereby constructing a plasmid for the production of the ⁇ -amylase, introducing the resulting plasmid into a microorganism such as Bacillus subtilis or Escherichia coli , preferably, Bacillus subtilis and cultivating the resulting recombinant microorganism.
- a microorganism such as Bacillus subtilis or Escherichia coli , preferably, Bacillus subtilis and cultivating the resulting recombinant microorganism.
- the mutant ⁇ -amylase thus obtained has improved productivity by about 10 to 500% as shown later in Examples while maintaining biochemical properties as an enzyme, thus having excellent properties.
- the detergent compositions of the present invention may contain, in addition to the ⁇ -amylase of the invention, one or more than one enzymes selected from debranching enzymes (such as pullulanase, isoamylase and neopullulanase), ⁇ -glucosidase, glucoamylase, protease, cellulase, lypase, pectinase, protopectinase, pectate lyase, peroxidase, laccase and catalase.
- debranching enzymes such as pullulanase, isoamylase and neopullulanase
- ⁇ -glucosidase such as pullulanase, isoamylase and neopullulanase
- ⁇ -glucosidase such as pullulanase, isoamylase and neopullulanase
- the detergent composition may contain, in addition, components ordinarily added to a detergent, for example, surfactants such as anionic surfactants, amphoteric surfactants, nonionic surfactants and cationic surfactants, chelating agents, alkali agents, inorganic salts, anti-redeposition agents, chlorine scavengers, reducing agents, bleaching agents, fluorescent dye solubilizing agents, perfumes, anti-caking agents, enzyme activating agents, antioxidants, antiseptics, blueing agents, bleach activating agents, enzyme stabilizing agents and regulator.
- surfactants such as anionic surfactants, amphoteric surfactants, nonionic surfactants and cationic surfactants, chelating agents, alkali agents, inorganic salts, anti-redeposition agents, chlorine scavengers, reducing agents, bleaching agents, fluorescent dye solubilizing agents, perfumes, anti-caking agents, enzyme activating agents, antioxidants, antiseptics, blueing agents, bleach activating agents, enzyme
- the detergent compositions of the invention can be produced in a manner known per se in the art from a combination of the highly productive ⁇ -amylase available by the above-described method and the above-described known detergent components.
- the form of the detergent can be selected according to the using purpose and examples include liquid, powder and granule.
- the detergent compositions of the present invention are suited as laundry detergents, bleaching detergents, detergents for automatic dish washer, pipe cleaners, and artificial tooth cleaners, of which they are especially suited as laundry detergents, bleaching detergents and detergents for automatic dish washer.
- the highly productive mutant ⁇ -amylases of the invention are also usable as starch liquefying saccharifying compositions. Moreover, these mutant ⁇ -amylases, after addition thereto of one or more than one enzymes selected from glucoamylase, maltase, pullulanase, isoamylase and neopullulanase, can be allowed to act on starches.
- mutant ⁇ -amylases of the present invention are usable as a desizing composition of fibers and an enzyme such as pullulanase, isoamylase or neopullulanase can be incorporated in the composition.
- Amylase activity and protein content of the enzymes each produced from recombinant Bacillus subtilis were measured in accordance with the below-described methods.
- Amylase activity was measured by the 3,5-dinitrosalicylic acid method (DNS method). After reaction at 50° C. for 15 minutes in a reaction mixture of a 40 mM glycine-sodium hydroxide buffer (pH 10) containing soluble starch, the reducing sugar thus formed was quantitatively analyzed by the DNS method. As the titer of the enzyme, the amount of the enzyme which formed reducing sugar equivalent to 1 ⁇ mol of glucose in one minute was defined as one unit.
- the protein content was determined by “Protein Assay Kit” (product of Bio-Rad Laboratories) using bovine serum albumin as standard.
- strain Bacillus sp. KSM-K38 (FERM BP-6946) was obtained.
- Medium A Tryptone 1.5% Soytone 0.5% Sodium chloride 0.5% Colored starch 0.5% Agar 1.5% Na 2 Co 3 0.5% (pH 10)
- Medium B Tryptone 1.5% Soytone 0.5% Sodium chloride 0.5% Soluble starch 1.0% Na 2 CO 3 0.5% (pH 10)
- strain KSM-K38 The mycological properties of strain KSM-K38 are shown in Table 1.
- TABLE 1 Strain KSM-K38 (a) Observation under microscope Cells are rods of a size of 1.0 to 1.2 ⁇ m ⁇ 2.4 to 5.4 ⁇ m in the strain K36 and 1.0 to 1.2 ⁇ m ⁇ 1.8 to 3.8 ⁇ m in the strain K38, and form an elliptical endospore (1.0 to 1.2 ⁇ m ⁇ 1.2 to 1.4 ⁇ m) at their subterminals or center. They have flagella and are motile. Gram's staining is positive. Acid fastness: negative. (b) Growth in various culture mediums.
- the strains are alikaliphilic so that 0.5% sodium carbonate was added to the culture medium in the tests described hereinafter.
- Nutrient agar plate culture Growth of cells is good. Colony has a circular shape, with its surface being smooth and its peripheral end being smooth. The color of the colony is yellowish brown.
- Nutrient agar slant culture Cells can grow. Nutrient broth Cells can grow. Stab culture in nutrient-broth gelatin Growth of cells is good. Liquefaction of gelatin is not observed. Litmus milk medium No change in growth.
- the strain KSM-K38 was inoculated, followed by aerobic shaken culture at 30° C. for 2 days.
- the amylase activity (at pH 8.5) of each of the supernatants isolated by centrifugation was measured. As a result, the activity in 1 L of the culture medium was found to be 1177 U.
- Ammonium sulfate was added to the supernatant of the culture medium of the strain KSM-K38 obtained in Referential Example 2 to give 80% saturation, followed by stirring.
- the precipitate thus formed was collected and dissolved in a 10 mM tris-HCl buffer (pH 7.5) containing 2 mM CaCl 2 to dialyze the resulting solution against the buffer overnight.
- the dialysate was loaded on a DEAE-Toyopearl 650M column equilibrated with the same buffer and protein was eluted in a linear gradient of 0 to 1 M of NaCl in the same buffer.
- the active fraction obtained by gel filtration column chromatography after dialysis against the same buffer was dialyzed against the buffer, whereby purified enzyme exhibited a single band on polyacrylamide gel electrophoresis (gel concentration: 10%) and sodium dodecylsulfate (SDS) electrophoresis was obtained.
- the properties of the purified enzyme are as follows:
- amylose acts on starch, amylose, amylopectin and ⁇ -1,4-glycoside bond which is a partially degraded product thereof to degrade them and produce, from amylose, glucose (G1), maltose (G2), maltotriose (G3), maltotetraose (G4), maltopentaose (G5), maltohexaose (G6) and maltoheptaose (G7). But it does not act on pullulan.
- the temperature at which the enzyme loses its activity was examined by causing a temperature change in a 50 mM glycine-sodium hydroxide buffer (pH 10) and then, treating at each temperature for 30 minutes.
- the residual activity of the enzyme is 80% or more at 40° C. and about 60% even at 45° C.
- the molecular weight as measured by sodium-dodecylsulfate polyacrylamide gel electrophoresis is 55,000 ⁇ 5,000.
- Its isoelectric point as measured by isoelectric focusing electrophoresis is about 4.2.
- a surfactant such as sodium linear alkylbenzene sulfonate, alkyl sulfate ester sodium salt, polyoxyethylene alkylsulfate ester sodium salt, sodium ⁇ -olefin sulfonate, sodium ⁇ -sulfonated fatty acid ester, sodium alkylsulfonate, SDS, soap and softanol.
- genes encoding a mutant ⁇ -amylase (which will hereinafter be described as “ ⁇ RG”) having improved heat resistance and a mutant ⁇ -amylase (“ ⁇ RG-M202T”) having improved oxidant resistance as well as improved heat resistance were constructed, respectively, by deleting Arg 181 and Gly 182 of the ⁇ -amylase (“LAMY”) which was derived from the strain Bacillus sp. KSM-AP1378 (FERM BP-3048) and had the amino acid sequence represented by SEQ ID No. 1; and by, in addition to this mutation by deletion, substituting Thr for Met 202 of the amino acid sequence represented by SEQ ID No. 1.
- a gene encoding chimeric ⁇ -amylase between K38AMY and LAMY was constructed. Described specifically, with a chromosomal DNA of the strain KSM-K38 (FERM BP6946) as a template, PCR reaction was conducted using primers K38DH (SEQ ID No. 8) and LA-K38 (SEQ ID No. 10) shown in Table 2, whereby a fragment encoding the sequence from Gln 20 downstream to the C-terminal of the amino acid sequence of K38AMY represented by SEQ ID No. 2 was amplified.
- LA-K38AMY chimeric ⁇ -amylase
- mutagenesis was effected in accordance with the method of the kit and by using the reaction product, the strain Escherichia coli MV1184 (“Competent cell MV1184”, product of Takara Shuzo Co., Ltd.) was transformed. From the transformant thus obtained, a recombinant plasmid was extracted, followed by analysis of a basic sequence, whereby mutation by substitution of Phe for Asn 190 was confirmed.
- primers A209V (SEQ ID No. 51) and QEYK SEQ ID No.
- PCR reaction was conducted using primers K38US (SEQ ID No. 7) and K38DH (SEQ ID No. 8) to amplify structural gene fragments (about 1.5 kb) encoding the mutant ⁇ -amylases were amplified. They were then inserted into the SalI-SmaI site of an expression vector pHSP64 in a similar manner as above, whereby a recombinant plasmid having structural genes of these mutant ⁇ -amylases bonded each other was constructed ( FIG. 1 ).
- PCR reactions were effected using primers CLUBG (SEQ ID No. 9) and LADH (SEQ ID No. 6) for ⁇ RG and ⁇ RG/M202T, while using primers CLUBG (SEQ ID No. 9) and K38DH (SEQ ID No.
- oligonucleotide primers for site-directed mutagenesis shown in Table 2 were 5′-phosphorylated with T4DNA kinase, and by using the resultant products and the above mutagenetic recombinant plasmids, mutagenesis was conducted in accordance with the method as described in the kit. With the reaction products, the strain Escherichia coli MV1184(“Competent Cell MV1184” product of Takara Shuzo Co., Ltd.) was transformed. From the resulting transformants, a recombinant plasmid was extracted, followed by analysis of a base sequence to confirm mutation. TABLE 2 SeQ ID Using No.
- PCR reaction was conducted using primers CLUBG (SEQ ID No. 9) and LADH (SEQ ID No. 6) or primers CLUBS (SEQ ID No. 9) and K38DH (SEQ ID No. 8) to amplify the mutated gene fragments. After they were cut with SalI, they were inserted into the site of SalI-SmaI site of an expression vector pHSP64, whereby various plasmids for producing mutant ⁇ -amylases were constructed ( FIG. 1 ).
- the various plasmids for producing mutant ⁇ -amylases obtained in Example 2 were each introduced into the strain Bacillus subtilis ISW1214 (leuA metB5 hsdM1) in accordance with the protoplast method.
- the recombinant Bacillus subtilis thus obtained was cultivated at 30+ C. for 4 days in a liquid medium (corn steep liquor, 4%; tryptose, 1%; meet extract, 1%, monopotassium phosphate, O.1%, magnesium sulfate, 0.01%, maltose, 2%, calcium chloride, 0.1%, tetracycline, 15 ⁇ g/mL).
- the activity of each of the various mutant ⁇ -amylases was measured using the supernatant of the culture medium.
- Each of an enzyme having Pro 86 of ⁇ RG substituted with Ser (which will hereinafter be abbreviated as “P18S/ ⁇ RG”), an enzyme having Gln 86 substituted with Glu (“Q86E/ ⁇ RG”), an enzyme having Glu 130 substituted with Val (“E130V/ ⁇ RG”), an enzyme having Asn 154 substituted with Asp (“N154D/ ⁇ RG”), an enzyme having Arg 171 substituted with Cys (“R171C/ ⁇ RG”), an enzyme having Ala 186 substituted with Val (“A186V/ ⁇ RG”), an enzyme having Glu 212 substituted with Asp (“E212D/ ⁇ RG”), an enzyme having Val 222 substituted with Glu (“V222E/ ⁇ RG”), an enzyme having Tyr 243 substituted with Cys (“Y243C/ ⁇ RG”) , an enzyme having Pro 260 substituted with Glu (“P260E/ ⁇ RG”), an enzyme having Lys 269 substituted with Gln (“K269E/ ⁇ RG”), an enzyme having Glu 276 substitute
- Any one of the mutant enzymes exhibited higher amylase productivity than ⁇ RG, indicating that mutation heightened productivity of ⁇ -amylase in recombinant Bacillus subtilis.
- the productivity of each of E130V/ ⁇ RG, A186V/ ⁇ RG, E212D/ ⁇ RG, Y243C/ ⁇ RG, N277S/ ⁇ RG and W439R/ ⁇ RG was found to be at least 3 times greater than that of ⁇ RG and above all, A186V/ ⁇ RG exhibited eminently high productivity of almost 5 times greater than that of ⁇ RG.
- each of an enzyme having Pro 18 of ⁇ RG/MT substituted with Thr (which will hereinafter be abbreviated as “P18T/ ⁇ RG/MT”), an enzyme having Gln86 substituted with Glu (“Q86E/ ⁇ RG/MT”), an enzyme having Glu 130 substituted with Val (“E130V/ ⁇ RG/MT”), an enzyme having Ala 186 substituted with Asn (“A186N/ ⁇ RG/MT”), an enzyme having Tyr 243 substituted with Ser (“Y243S/ ⁇ RG/MT”), an enzyme having Asn 277 substituted with Phe (“N277F/ ⁇ RG/MT), and an enzyme having Asn 471 substituted with Glu (“N471E/ ⁇ RG/MT”) was assayed for amylase productivity.
- P18T/ ⁇ RG/MT an enzyme having Gln86 substituted with Glu
- Q86E/ ⁇ RG/MT an enzyme having Glu 130 substituted with Val
- E130V/ ⁇ RG/MT an enzyme having Ala 186 substituted with Asn
- any one of the above-described mutant enzymes exhibited high amylase productivity compared with ⁇ RG/MT, and in particular, the productivity of each of E130V/ ⁇ RG/MT and A186N/ ⁇ RG/MT was at least 3 times greater than that of ⁇ RG/MT.
- each of an enzyme having Asp 128 of K38AMY substituted with Val (which will hereinafter be abbreviated as “D128V”), an enzyme having Gly 140 substituted with Ser (“G140S”), an enzyme having Ser 144 substituted with Pro (“S144P”), an enzyme having Arg 168 substituted with Gln (“R168Q”), an enzyme having Asn 181 substituted with Val (“N181V”), an enzyme having Glu 207 substituted with Asp (“E207D”), an enzyme having Phe 272 substituted with Ser (“F272S”), an enzyme having Ser 375 substituted with Pro (“S375P”), an enzyme having Trp 434 substituted with Arg (“W434R”), and an enzyme having Glu 466 substituted with Asp (“E466D”) was assayed for amylase productivity.
- K38AMY was employed as a control. The results are shown in Table 5. TABLE 5 Relative amylase Enzyme productivity (%) K38AMY 100 D128V 325 G140S 209 S144P 197 R168Q 264 N181V 207 E207D 109 F272S 175 S375P 115 W434R 124 E466D 212
- any one of the mutant enzymes exhibited high amylase productivity and in particular, D128V exhibited high productivity at least 3 times greater than that of K38AMY.
- a mutant enzyme S144P/N181V (which will hereinafter be abbreviated as “SPNV”) having, among the mutants shown in Example 6, S144P and N181V in combination was assayed for amylase productivity in accordance with the method as described in Example 3.
- SPNV mutant enzyme S144P/N181V
- K38AMY, S144P and N181V were employed. The results are shown in Table 6. TABLE 6 Relative amylase Enzyme productivity (%) K38AMY 100 S144P 197 N181V 207 SPNV 257
- each of an enzyme obtained by substituting Arg 168 of the gene of a heat-resistance improved enzyme LA-K38AMY/NFQV with Gln (which will hereinafter be abbreviated as “R168Q/LA-K38AMY/NFQV”)
- an enzyme obtained by substituting Glu 466 of the above-described gene with Asp (“E466D/LA-K38AMY/NFQV”)
- an enzyme having double mutations of Example 6 introduced into the gene (“SPNV/LA-K38AMY/NFQV”) was assayed for amylase productivity.
- LA-K38AMY/NFQV was employed. The results are shown in Table 7.
- any one of the mutant enzymes obtained in this Example exhibited high amylase productivity at least about 1.5 times greater than that of LA-K38AMY/NFQV and in particular, R168Q/LA-K38AMY/NFQV exhibited about 3 times greater productivity.
- each of an enzyme obtained by substituting Asp 128 of the gene of a heat-resistance improved enzyme LA-K38AMY/QEYK/NFQV with Val (which will hereinafter be abbreviated as “D128V/LA-K38AMY/QEYK/NFQV”) and an enzyme having double mutations of Example 6 introduced into the gene (“SPNV/LA-K38AMY/QEYK/NFQV”) was assayed for amylase productivity.
- LA-K38AMY/QEYK/NFQV was employed as ayed for amylase productivity.
- Table 8 The results are shown in Table 8.
- any one of the mutant enzymes obtained in this Example exhibited markedly high amylase productivity compared with LA-K38AMY/QEYK/NFQV and in particular, D128V/LA-K38AMY/QEYK/NFQV exhibited drastic increase (about 6 times) in productivity.
- the relative amylase productivity of the mutant enzyme ML/DV/LA-K38AMY/QEYK/NFQV was 115%, indicating that introduction of M107L mutation for reinforcing oxidant resistance did not adversely affect high productivity of amylase in recombinant Bacillus subtilis.
- mutant enzyme exhibited productivity of at least 2 times greater than that of QEYK/NFQV.
- a detergent composition for automatic dish washer having the composition as shown in Table 12 was prepared, followed by incorporation therein of various mutant enzymes obtained in the productivity increasing method. As a result, the highly productive mutant enzymes exhibited similar or superior detergency to the control enzyme when they were equal in activity.
- TABLE 12 Composition of detergent (%) Pluronic L-61 2.2 Sodium carbonate 24.7 Sodium bicarbonate 24.7 Sodium percarbonate 10.0 No. 1 sodium silicate 12.0 Trisodium citrate 20.0
- mutant ⁇ -amylases are available at a high yield from recombinant microorganisms, making it possible to largely reduce the cost of their industrial production.
- the mutation for productivity increase in the present invention does not adversely affect biochemical properties of the enzymes so that highly productive liquefying alkaline ⁇ -amylases having heat resistance, chelating agent resistance and oxidant resistance and being useful as enzymes for a detergent can be produced.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
Abstract
The invention relates to mutant α-amylases that may be produced at high yield from recombinant microorganisms.
Description
- The present invention relates to mutant α-amylases having improved productivity.
- α-Amylases [EC.3.2.1.1.] have been used in a wide range of industrial fields such as starch industry, brewing industry, fiber industry, pharmaceutical industry and food industry. Among them, those capable of degrading starches at high random are suited for detergents. Conventionally known as such are, as well as α-amylases derived from Bacillus licheniformis, liquefying alkaline α-amylases derived from the alkaliphilic strain Bacillus sp. KSM-AP1378 (FERM BP-3048) (WO94/26881) and improved enzymes having improved heat resistance and oxidant resistance (WO98/44126).
- The present inventors have recently found liquefying alkaline α-amylases derived from the alkaliphilic strain Bacillus sp. KSM-K38 (FERM BP-6946) and having chelating-agent- and oxidation-resistance (Japanese Patent Application No. Hei 10-362487, Japanese Patent Application No. Hei 10-362488); and improved enzymes having improved heat resistance (Japanese Patent Application No. Hei 11-163569).
- In addition to such properties, enzymes for detergents are required to have high productivity in consideration of their industrial production. Although various trials have been made to improve the heat resistance or oxidant resistance of α-amylases for detergent by using protein engineering technique, neither improvement of productivity has been considered sufficiently nor an attempt of production increase by mutation of a structural gene has been reported yet.
- An object of the present invention is to provide mutant α-amylases having excellent productivity.
- The present inventors introduced, in microorganisms, mutant α-amylase structural gene constructed by site-directed mutagenesis and evaluated productivity of α-amylases. As a result, it has been found that since an (α-amylase gene has a site taking part in the improvement of productivity, introduction, into a microorganism, of a recombinant gene having this site mutated makes it possible to produce α-amylases having drastically improved productivity.
- In one aspect of the present invention, there is thus provided a mutant α-amylase which is derived from an α-amylase having an amino acid sequence represented by SEQ ID No. 1 or showing at least 60% homology thereto by substitution or deletion of at least one amino acid residue corresponding to any one of Pro19, Gln86, Glu130, Asn154, Arg171, Ala186, Glu212, Val222, Tyr243, Pro260, Lys269, Glu276, Asn277, Arg310, Glu360, Gln391, Trp439, Lys444, Asn471 and Gly476 of the amino acid sequence.
- In another aspect of the present invention, there is also provided a mutant α-amylase derived from an α-amylase having an amino acid sequence represented by SEQ ID No. 2 or showing at least 60% homology thereto by substitution or deletion of at least one amino acid residue corresponding to any one of Asp128, Gly140, Ser144, Arg168, Asn181, Glu207, Phe272, Ser375, Trp434 and Glu466 of the amino acid sequence.
- In a further aspect of the present invention, there is also provided a gene encoding this mutant α-amylase, a vector containing the gene, a cell transformed with the vector and a production method of a mutant α-amylase which comprises cultivating the transformed cell.
- In a still further aspect of the present invention, there is also provided a detergent composition containing this mutant α-amylase.
-
FIG. 1 illustrates a method of constructing a recombinant plasmid for production of an α-amylase derived from the strain KSM-1378 or KSM-K38. -
FIG. 2 is a schematic view illustrating a method of introducing a mutation into an α-amylase gene derived from the strain KSM-1378 or KSM-K38. - The term “highly productive mutant α-amylase” as used herein means an α-amylase whose yield is increased, upon production of it by cultivating a recombinant microorganism, by at least 5%, preferably at least 10%, more preferably at least 20% compared with that before mutation.
- The mutant α-amylase of the present invention is constructed so that out of amino acids constituting the α-amylase, the amino acid residues taking part in the productivity are substituted with another amino acid residues or deleted. Examples of the α-amylase usable here include liquefying α-amylases derived from Bacillus. amyloliquefaciens or Bacillus. licheniformis and liquefying alkaline α-amylases derived from alkaliphilic microorganisms belonging to the Bacillus sp., of which α-anylases having an amino acid sequence represented by SEQ ID No. 1 or SEQ ID No. 2 and α-amylases having at least 60% homology to the above-described amino acid sequence are preferred.
- Examples of the α-amylase having the amino acid sequence represented by SEQ ID No. 1 or α-amylase having at least 60% homology thereto include liquefying alkaline α-amylases derived from the strain Bacillus sp. KSM-AP1378 (FERM BP-3048) (Japanese Patent Application Laid-Open No. Hei 8-336392) and improved enzymes of the above-described one in heat resistance and oxidant resistance which are constructed by protein engineering technique (WO98/44126).
- Examples of the α-amylase having the amino acid sequence represented by SEQ ID No. 2 or having at least 60% is homology thereto include liquefying alkaline α-amylases derived from the strain Bacillus sp. KSM-K38 (FERM BP-6946) and improved enzymes of the above-described one in heat resistance which are constructed by protein engineering technique (Japanese Patent Application No. Hei 11-163569).
- The homology of an amino acid sequence is calculated by Lipman-Pearson method (Science, 227, 1435(1985)).
- The mutant α-amylase of the present invention can be obtained first by cloning, from a microorganism producing an α-amylase, a gene encoding the α-amylase. For this purpose, ordinarily employed gene recombinant technique, for example, the method as described in Japanese Patent Application Laid-Open No. Hei 8-336392 may be employed. Examples of the gene usable here include that represented by SEQ ID No. 3 or SEQ ID No. 4 which encodes the amino acid sequence represented by SEQ ID No. 1 or SEQ ID No. 2. Mutant genes derived from the above-described ones and having improved heat resistance and oxidant resistance are also usable.
- For mutation of the gene thus obtained by cloning, any site-directed mutagenesis ordinarily employed can be adopted. For example, mutation can be conducted using a “Site-Directed Mutagenesis System Mutan-Super Express Km” kit (product of Takara Shuzo Co., Ltd.).
- Mutation for obtaining highly productive α-amylases of the invention can be attained, for example, by substitution or deletion, in an α-amylase having an amino acid sequence represented by SEQ ID No. 1 or having at least 60% homology thereto, of at least one amino acid residue corresponding to any one of Pro18, Gln86, Glu130, Asn154, Arg171, Ala186, Glu212, Val222, Tyr243, Pro260, Lys269, Glu276, Asn277, Arg310, Glu360, Gln391, Trp439, Lys444, Asn471 and Gly476 of the amino acid sequence; or by substitution or deletion, in another α-amylase having an amino acid sequence represented by SEQ ID No. 2 or having at least 60% homology thereto, of at least one amino acid residue corresponding to any one of AsP128, Gly140, Ser144, Arg168, Asn181, Glu207, Phe272, Ser375, Trp434 and Glu466 of the amino acid sequence. Preferred mutations include, in the amino acid sequence of SEQ ID No. 1, substitution of the amino acid residue corresponding to Pro18 with Ser or Thr, the amino acid residue corresponding to Gln86 with Glu, the amino acid residue corresponding to Glu130 with Val or Gln, the amino acid residue corresponding to Asn154 with Asp, the amino acid residue corresponding to Arg171 with Cys or Gln, the amino acid residue corresponding to Ala186 with Val or Asn, the amino acid residue corresponding to Glu212 with Asp, the amino acid residue corresponding to Val222 with Glu, the amino acid residue corresponding to Tyr243 with Cys or Ser, the amino acid residue corresponding to Pro260 with Glu, the amino acid residue corresponding to Lys269 with Gln, the amino acid residue corresponding to Glu276 with His, the amino acid residue corresponding to Asn277 with Ser or Phe, the amino acid residue corresponding to Arg310 with Ala, the amino acid residue corresponding to Glu360 with Gln, the amino acid residue corresponding to Gln391 with Glu, the amino acid residue corresponding to Trp439 with Arg, the amino acid residue corresponding to Lys444 with Arg, the amino acid residue corresponding to Asn471 with Asp or Glu, or the amino acid residue corresponding to Gly476 with Asp;
- or substitution, in the amino acid sequence of SEQ ID No. 2, of the amino acid residue corresponding to ASP128 with Val or Gln, the amino acid residue corresponding to Gly140 with Ser, the amino acid residue corresponding to Ser144 with Pro, the amino acid residue corresponding to Arg168 with Gln, the amino acid residue corresponding to Gln181 with Val, the amino acid residue corresponding to Glu270 with Asp, the amino acid residue corresponding to Phe272 with Ser, the amino acid residue corresponding to Ser375 with Pro, the amino acid residue corresponding to Trp434 with Arg or the amino acid residue corresponding to Glu466 with Asp.
- Among the mutations of the amino acid sequence of SEQ ID No. 1, those by substitution of the amino acid residue corresponding to Gln86 with Glu, the amino acid residue corresponding to Glu130 with Val or Gln, the amino acid residue corresponding to Ala186 with Asn, the amino acid residue corresponding to Tyr243 with Ser, the amino acid residue corresponding to Pro260 with Glu, the amino acid residue corresponding to Lys269 with Gln, the amino acid residue corresponding to Asn277 with Phe and the amino acid residue corresponding to Asn471 with Asp or Glu can bring about improvement in solubility of the α-amylase in a culture medium or desalted and concentrated solution thereof. More specifically, the above-described mutations make it possible to improve the residual activity of the α-amylase in the supernatant after storage at 4° C. for one week in a desalted and concentrated solution by at least 5%, especially 10% compared with the activity before mutation. Accordingly, in the case of the mutant α-amylases of the present invention obtained by such amino acid mutations, a fermented concentrate solution of a high concentration is available at a high yield and enzyme formulation treatment such as ultrafiltration after fermentation production can be conducted efficiently.
- A combination of two or more substitutions or deletions of various amino acid residues is also effective for such amino acid mutations. It is also possible to use the above-exemplified mutation in combination with a mutation for improving enzymatic properties, for example, in an α-amylase having an amino acid sequence represented by SEQ ID No. 1 or having at least 60% homology thereto, a mutation for improving heat resistance by deleting amino acid residues corresponding to Arg181, and Gly182, a mutation for improving oxidant resistance by substituting the amino acid residue corresponding to Met222 with Thr or a mutation for improving solubility by substituting the amino acid residue corresponding Lys484 with Gln; or in an α-amylase having an amino acid sequence represented by SEQ ID No. 2 or having at least 60% homology thereto, a mutation for further reinforcing oxidant resistance by substituting the amino acid residue corresponding to Met107 with Leu or a mutation for heightening detergency of a laundry detergent by substituting the amino acid residue corresponding Glu188 with Ile.
- A mutant α-amylase is available at a high yield by appropriately combining a mutant α-amylase structural gene with a control gene and a proper plasmid vector, thereby constructing a plasmid for the production of the α-amylase, introducing the resulting plasmid into a microorganism such as Bacillus subtilis or Escherichia coli, preferably, Bacillus subtilis and cultivating the resulting recombinant microorganism.
- The mutant α-amylase thus obtained has improved productivity by about 10 to 500% as shown later in Examples while maintaining biochemical properties as an enzyme, thus having excellent properties. By the above-described mutation of the amino acid residues of liquefying alkaline α-amylases having heat resistance, chelating agent resistance, oxidant resistance and high solubility, it is therefore possible to create useful enzymes having drastically improved productivity in a recombinant microorganism without losing the above-described original properties.
- The detergent compositions of the present invention may contain, in addition to the α-amylase of the invention, one or more than one enzymes selected from debranching enzymes (such as pullulanase, isoamylase and neopullulanase), α-glucosidase, glucoamylase, protease, cellulase, lypase, pectinase, protopectinase, pectate lyase, peroxidase, laccase and catalase.
- The detergent composition may contain, in addition, components ordinarily added to a detergent, for example, surfactants such as anionic surfactants, amphoteric surfactants, nonionic surfactants and cationic surfactants, chelating agents, alkali agents, inorganic salts, anti-redeposition agents, chlorine scavengers, reducing agents, bleaching agents, fluorescent dye solubilizing agents, perfumes, anti-caking agents, enzyme activating agents, antioxidants, antiseptics, blueing agents, bleach activating agents, enzyme stabilizing agents and regulator.
- The detergent compositions of the invention can be produced in a manner known per se in the art from a combination of the highly productive α-amylase available by the above-described method and the above-described known detergent components. The form of the detergent can be selected according to the using purpose and examples include liquid, powder and granule. The detergent compositions of the present invention are suited as laundry detergents, bleaching detergents, detergents for automatic dish washer, pipe cleaners, and artificial tooth cleaners, of which they are especially suited as laundry detergents, bleaching detergents and detergents for automatic dish washer.
- The highly productive mutant α-amylases of the invention are also usable as starch liquefying saccharifying compositions. Moreover, these mutant α-amylases, after addition thereto of one or more than one enzymes selected from glucoamylase, maltase, pullulanase, isoamylase and neopullulanase, can be allowed to act on starches.
- Furthermore, the mutant α-amylases of the present invention are usable as a desizing composition of fibers and an enzyme such as pullulanase, isoamylase or neopullulanase can be incorporated in the composition.
- Measurement of amylase activity and protein content Amylase activity and protein content of the enzymes each produced from recombinant Bacillus subtilis were measured in accordance with the below-described methods.
- Amylase activity was measured by the 3,5-dinitrosalicylic acid method (DNS method). After reaction at 50° C. for 15 minutes in a reaction mixture of a 40 mM glycine-sodium hydroxide buffer (pH 10) containing soluble starch, the reducing sugar thus formed was quantitatively analyzed by the DNS method. As the titer of the enzyme, the amount of the enzyme which formed reducing sugar equivalent to 1 μmol of glucose in one minute was defined as one unit.
- The protein content was determined by “Protein Assay Kit” (product of Bio-Rad Laboratories) using bovine serum albumin as standard.
- About 0.5 g of soil was suspended in sterilized water and the resulting suspension was heat treated at 80° C. for 15 minutes. The supernatant of the heat treated mixture was diluted with an adequate amount of sterilized water, followed by applying to an isolating agar medium (Medium A). The medium was then cultured at 30° C. for 2 days to grow colonies. The colonies which formed transparent zones in their peripheries due to starch dissolution were selected and isolated as amylase producing strains. The resulting isolated strains were inoculated in Medium B, followed by aerobic shaken culture at 30° C. for 2 days. After cultivation, the chelating agent (EDTA) resisting capacity of the supernatant obtained by centrifugation was measured and in addition, the optimum working pH was measured. Thus, strain Bacillus sp. KSM-K38 (FERM BP-6946) was obtained.
Medium A: Tryptone 1.5% Soytone 0.5% Sodium chloride 0.5% Colored starch 0.5% Agar 1.5% Na2Co3 0.5% (pH 10) Medium B: Tryptone 1.5% Soytone 0.5% Sodium chloride 0.5% Soluble starch 1.0% Na2CO3 0.5% (pH 10) - The mycological properties of strain KSM-K38 are shown in Table 1.
TABLE 1 Strain KSM-K38 (a) Observation under microscope Cells are rods of a size of 1.0 to 1.2 μm × 2.4 to 5.4 μm in the strain K36 and 1.0 to 1.2 μm × 1.8 to 3.8 μm in the strain K38, and form an elliptical endospore (1.0 to 1.2 μm × 1.2 to 1.4 μm) at their subterminals or center. They have flagella and are motile. Gram's staining is positive. Acid fastness: negative. (b) Growth in various culture mediums. The strains are alikaliphilic so that 0.5% sodium carbonate was added to the culture medium in the tests described hereinafter. Nutrient agar plate culture Growth of cells is good. Colony has a circular shape, with its surface being smooth and its peripheral end being smooth. The color of the colony is yellowish brown. Nutrient agar slant culture Cells can grow. Nutrient broth Cells can grow. Stab culture in nutrient-broth gelatin Growth of cells is good. Liquefaction of gelatin is not observed. Litmus milk medium No change in growth. (c) Physiological properties Nitrate reduction and denitrification Nitrate reduction: positive Denitrification: negative MR test Indeterminable because the medium is an alkaline medium. V-P test Negative Production of indole Negative Production of hydrogen sulfide Negative Hydrolysis of starch Positive Utilization of citric acid Positive in Christensen's medium but negative in Koser's medium and Simmon's medium. Utilization of inorganic nitrogen sources Nitrate is utilized but ammonium salts are not. Production of colorants Negative Urease Negative Oxidase Negative Catalase Positive Growth range Growth temperature range: 15 to 40° C., optimum growth temperature: 30° C., growth pH range: pH 9.0 to 11.0, optimum growth pH range: same Behavior on oxygen Aerobic O-F test Cells do not grow Sugar utilization L-galactose, D-xylose, L-arabinose, lactose, glycerin, melibiose, ribose, D-glucose, D-mannose, maltose, sucrose, trehalose, D-mannitol, starch, raffinose and D-fructose are utilized. Growth in a salt-containing medium Cells can grow when salt concentration is 12%, but not when salt concentration is 15%. - In the liquid medium B of Referential Example 1, the strain KSM-K38 was inoculated, followed by aerobic shaken culture at 30° C. for 2 days. The amylase activity (at pH 8.5) of each of the supernatants isolated by centrifugation was measured. As a result, the activity in 1 L of the culture medium was found to be 1177 U.
- Ammonium sulfate was added to the supernatant of the culture medium of the strain KSM-K38 obtained in Referential Example 2 to give 80% saturation, followed by stirring. The precipitate thus formed was collected and dissolved in a 10 mM tris-HCl buffer (pH 7.5) containing 2 mM CaCl2 to dialyze the resulting solution against the buffer overnight. The dialysate was loaded on a DEAE-Toyopearl 650M column equilibrated with the same buffer and protein was eluted in a linear gradient of 0 to 1 M of NaCl in the same buffer. The active fraction obtained by gel filtration column chromatography after dialysis against the same buffer was dialyzed against the buffer, whereby purified enzyme exhibited a single band on polyacrylamide gel electrophoresis (gel concentration: 10%) and sodium dodecylsulfate (SDS) electrophoresis was obtained.
- The properties of the purified enzyme are as follows:
- (1) Action
- It acts on starch, amylose, amylopectin and α-1,4-glycoside bond which is a partially degraded product thereof to degrade them and produce, from amylose, glucose (G1), maltose (G2), maltotriose (G3), maltotetraose (G4), maltopentaose (G5), maltohexaose (G6) and maltoheptaose (G7). But it does not act on pullulan.
- (2) pH Stability (Britton-Robinson Buffer)
- It exhibits residual activity of 70% or more within a range of pH 6.5 to 11.0 under treating conditions at 40° C. for 30 minutes.
- (3) Working Temperature Range and Optimum Working Temperature
- It acts in a wide temperature range of from 20 to 80° C., with the optimum working temperature being 50 to 60° C.
- (4) Temperature Stability
- The temperature at which the enzyme loses its activity was examined by causing a temperature change in a 50 mM glycine-sodium hydroxide buffer (pH 10) and then, treating at each temperature for 30 minutes. The residual activity of the enzyme is 80% or more at 40° C. and about 60% even at 45° C.
- (5) Molecular Weight
- The molecular weight as measured by sodium-dodecylsulfate polyacrylamide gel electrophoresis is 55,000±5,000.
- (6) Isoelectric Point
- Its isoelectric point as measured by isoelectric focusing electrophoresis is about 4.2.
- (7) Effects of Surfactants
- It is almost free from activity inhibition (activity remaining ratio: 90% or more) even when treated at pH 10 and 30° C. for 30 minutes in a 0.1% solution of a surfactant such as sodium linear alkylbenzene sulfonate, alkyl sulfate ester sodium salt, polyoxyethylene alkylsulfate ester sodium salt, sodium α-olefin sulfonate, sodium α-sulfonated fatty acid ester, sodium alkylsulfonate, SDS, soap and softanol.
- (8) Effects of Metal Salts
- It was treated at pH 10 and 30° C. for 30 minutes in each of the reaction systems containing various metal salts and their effects were studied. Its activity is inhibited by 1 mM of Mn2+ (inhibition ratio: about 75%) and slightly inhibited by 1 mM of Sr2+ and Cd2+ (inhibition ratio: about 30%).
- In accordance with the method as described in WO98/44126, genes encoding a mutant α-amylase (which will hereinafter be described as “ΔRG”) having improved heat resistance and a mutant α-amylase (“ΔRG-M202T”) having improved oxidant resistance as well as improved heat resistance were constructed, respectively, by deleting Arg181 and Gly182 of the α-amylase (“LAMY”) which was derived from the strain Bacillus sp. KSM-AP1378 (FERM BP-3048) and had the amino acid sequence represented by SEQ ID No. 1; and by, in addition to this mutation by deletion, substituting Thr for Met202 of the amino acid sequence represented by SEQ ID No. 1. With the genes as a template, gene fragments (about 1.5 kb) encoding these mutant α-amylases were amplified by the PCR reaction using primers LAUS (SEQ ID No. 5) and LADH (SEQ ID No. 6). After cutting of them with a restriction enzyme SalI, each of the fragments was inserted into the SalI-SmaI site of an expression vector pHSP64 (Japanese Patent Application Laid-Open No. Hei 6-217781), whereby a recombinant plasmid having a structural gene of each of the mutant α-amylases bonded thereto was constructed downstream of a strong promoter derived from an alkaline cellulase gene of the strain Bacillus sp. KSM-64 (FERM P-10482).
- In the meantime, with a chromosomal DNA, which had been extracted from the cells of the strain Bacillus sp. KSM-K38 (FERM BP-6946) by the method of Saito and Miura (Biochim. Biophys. Acta, 72, 619(1961)), as a template, PCR reaction was effected using primers K38US (SEQ ID No. 7) and K38DH (SEQ ID No. 8) shown in Table 2, whereby a structural gene fragment (about 1.5 kb) encoding an α-amylase (which will hereinafter be described as “K38AMY”) having an amino acid sequence of SEQ ID No. 2 was amplified. After cutting of it with a restriction enzyme SalI, the resulting fragment was inserted into the SalI-SmaI site of an expression vector pHSP64 to construct, downstream of a strong promoter derived from an alkaline cellulase gene of the strain Bacillus sp. KSM-64 (FERM P-10482) contained in pHSP64, a recombinant plasmid having a structural gene of K38AMY bonded thereto (
FIG. 1 ). With this recombinant plasmid as a template, PCR reaction was effected using the primers CLUBG (SEQ ID. No. 9) and K38DH (SEQ. ID. 8) to amplify a gene fragment (about 2.1 kb) having the strong promoter and K38AMY bonded thereto. - By the recombinant PCR method as described below, a gene encoding chimeric α-amylase between K38AMY and LAMY was constructed. Described specifically, with a chromosomal DNA of the strain KSM-K38 (FERM BP6946) as a template, PCR reaction was conducted using primers K38DH (SEQ ID No. 8) and LA-K38 (SEQ ID No. 10) shown in Table 2, whereby a fragment encoding the sequence from Gln20 downstream to the C-terminal of the amino acid sequence of K38AMY represented by SEQ ID No. 2 was amplified. With the above-described recombinant plasmid containing the LAMY gene and strong promoter as a template, PCR reaction was conducted using primers CLUBG (SEQ ID No. 9) and LA-K38R (SEQ ID No. 11) shown in Table 2, whereby a gene fragment encoding from the upstream strong promoter to Gly21 of the amino acid sequence of LAMY of SEQ ID No. 1 was amplified. By the second PCR reaction using the resulting two DNA fragments and primers CLUBG (SEQ ID No. 9) and K38DH (SEQ ID No. 8) shown in Table 2, the resulting two fragments having, at the end thereof, complementary sequences derived from primers LA-K38 (SEQ ID No. 10) and LA-K38R (SEQ ID No. 11) respectively were combined, whereby a gene fragment (about 2.1 kb) encoding a chimeric α-amylase (which will hereinafter be described as “LA-K38AMY”) which has, successively bonded thereto, a region encoding from His1 to Gly21 of the LAMY downstream of the strong promoter and a region encoding from Gln20 to the C-terminal of the K38AMY was amplified.
- By using a “Site-Directed Mutagenesis System Mutan-Super Express Km”kit (product of Takara Shuzo Co., Ltd.), the below-described mutations were introduced to the K38AMY and LA-K38AMY. First, the K38AMY and LA-K3.8AMY gene fragments (about 2.1 kb) were inserted into the site SmaI of a plasmid vector pKF19k attached to the kit to construct a mutagenic recombinant plasmid (
FIG. 2 ). A site-directed mutagenic oligonucleotide primer N19OF (SEQ ID No. 50) shown in Table 2 was 5′-phosphorylated with T4 DNA kinase. Using this and the above-described mutagenic recombinant plasmid, mutagenesis was effected in accordance with the method of the kit and by using the reaction product, the strain Escherichia coli MV1184 (“Competent cell MV1184”, product of Takara Shuzo Co., Ltd.) was transformed. From the transformant thus obtained, a recombinant plasmid was extracted, followed by analysis of a basic sequence, whereby mutation by substitution of Phe for Asn190 was confirmed. By repeated introduction of mutagenic reactions into the mutated gene by successively using primers A209V (SEQ ID No. 51) and QEYK (SEQ ID No. 49) in a similar manner as above, thereby substituting Asn190 and Gln209, each of the amino acid sequence of the K38AMY represented by SEQ ID No. 2, with Phe and Val, respectively, and the sequence from Asp1 to Gly19 of the amino acid sequence of the K38AMY represented by SEQ ID No. 2 with the sequence from His1 to Gly21 of the amino acid sequence of the LAMY represented by SEQ ID NO. 1; by substituting Gln167, Tyr169, Asn190 and Gln209, each of the amino acid sequence of the K38AMY, with Glu, Lys, Phe and Val, respectively and the sequence from Asp1 to Gly19 of the amino acid sequence of the K38AMY with the sequence from His1 to Gly21 of the amino acid sequence of the LAMY; and substituting Gln167 and Tyr169, Asn190 and Gln209, each of the amino acid sequence of the K38AMY, with Glu, Lys, Phe and Val, respectively, genes encoding a mutant α-amylase (which will hereinafter be described as “LA-K38AMY/NFQV”) having improved heat resistance, a mutant α-amylase (“LA-K38AMY/QEYK/NFQV”) having drastically improved heat resistance, and a mutant α-amylase (“QEYK/NFQV”) having improved heat resistance were constructed, respectively. - With these genes as a template, PCR reaction was conducted using primers K38US (SEQ ID No. 7) and K38DH (SEQ ID No. 8) to amplify structural gene fragments (about 1.5 kb) encoding the mutant α-amylases were amplified. They were then inserted into the SalI-SmaI site of an expression vector pHSP64 in a similar manner as above, whereby a recombinant plasmid having structural genes of these mutant α-amylases bonded each other was constructed (
FIG. 1 ). - A “Site-Directed Mutagenesis System Mutan-Super Express Km” kit of Takara Shuzo Co., Ltd. was used for site-directed mutagenesis for improving amylase productivity of recombinant Bacillus subtilis. With various recombinant plasmids obtained in Example 1 as a template, PCR reactions were effected using primers CLUBG (SEQ ID No. 9) and LADH (SEQ ID No. 6) for ΔRG and ΔRG/M202T, while using primers CLUBG (SEQ ID No. 9) and K38DH (SEQ ID No. 8) for K38AMY, LA-K38AMY/NFQV, LA-K38AMY/QEYK/NFQV and QEYK/NFQV, whereby fragments of about 2.1 kb from the upstream strong promoter derived from the strain KSM-64 to the downstream α-amylase gene were amplified. These amplified fragments were inserted into the SmaI site of a plasmid vector pKF19k attached to the above-described kit, whereby various mutagenetic recombinant plasmids were constructed (
FIG. 2 ). - Various oligonucleotide primers for site-directed mutagenesis shown in Table 2 (SEQ ID Nos. 12 to 51) were 5′-phosphorylated with T4DNA kinase, and by using the resultant products and the above mutagenetic recombinant plasmids, mutagenesis was conducted in accordance with the method as described in the kit. With the reaction products, the strain Escherichia coli MV1184(“Competent Cell MV1184” product of Takara Shuzo Co., Ltd.) was transformed. From the resulting transformants, a recombinant plasmid was extracted, followed by analysis of a base sequence to confirm mutation.
TABLE 2 SeQ ID Using No. Primer Base sequence (5′-3′) purpose 5 LAUS GAGTCGACCAGCACAAGCCCATCATAATGG PCR for 6 LADH TAAAGCTTCAATTTATATTGG recombi- 7 K38US GGGTCGACCAGCACAAGCCGATGGATTGAACGGTACGATG nation 8 K38DH TAAAGCTTTTGTTATTGGTTCACGTACAC 9 CLUBG CCAGATCTACTTACCATTTTAGAGTCA 10 LA-K38 ATTTGCCAAATGACGGGCAGCATTGGAATCGGTT 11 LA-K38R AACCGATTCCAATGCTGCCCGTCATTTGGCAAAT 12 P18S TTTGAATGGCATTTGTCAAATGACGGGGAACCAC Site-directed 13 Q86E ACAAGGAGTCAGTTGGAAGGTGCCGTGACATCT mutagenesis 14 E130V CGAAACCAAGTAATATCAGGT (ΔRG) 15 N154D AATACCCATTCCGATTTTAAATGGCGC 16 R171C GATTGGGATCAGTCATGYCAGCTTCAGAACAAA 17 A186V AAATTCACCGGAAAGGTATGGGACTGGGAAGTA 18 E212D TCATCCAGATGTAATCAATG 19 V222E CTTAGAAATTGGGGAGAATGGTATACAAATACA 20 Y243C GTGAAACATATTAAATGCAGCTATACGAGAGAT 21 P260E AACACCACAGGTAAAGAAATGTTTGCAGTTGCA 22 K269Q AGAATTTTGGCAAAATGACCT 23 E276H TTGCTGCAATCCATAACTATTTAAAT 24 N277S CTTGCTGCAATCGAAAGYTATTTAAATAAAACA 25 R310A GGCTATTTTGATATGGCAAATATTTTAAATGGT 26 E360Q TCTGACAAGGCAGCAAGGTTA 27 Q391E GATCCACTTCTGGAAGCACGTCAAACG 28 W439R GGGGGTAATAAAAGAATGTATGTCGGG 29 K444R ATGTATGTCGGGCGACATAAAGCTGG 30 N471D GATGGTTGGGGGGATTTCACTGTAA 31 G476D TTCACTGTAAACGATGGGGCAGTTTCG 32 K484Q GGTTTGGGTGCAGCAATAAAT 33 P18X TTTGAATGGCATTTGNNNAATGACGGGAACCAC Site-directed 34 A186X AAATTCACCGGAAAGNNNTGGGACTGGGAAGTA mutagenesis 35 Y243X GTGAAACATATTAAANNNAGCTATACGAGAGAT (for ΔRG/) 36 N277X CTTGCTGCAATCGAANNNTATTTAAATAAAACA M2027) 37 N471E GATGGTTGGGGGGAATTCACTGTAA 38 D128V CCAACGAATCGTTGGCAGGTAATTTCAGGTGCCTACACG Site-directed 39 G140S ATTGATGCGTGGACGAGTTTCGACTTTTCAGGG mutagenesis 40 S144P TTTCGACTTTCCAGGGCGTAA (for 41 R168Q GGTGTTGACTGGGATCAGCAATATCAAGAAAATCATATTTTCC K38AMY) 42 N181V CATATTTTCCGCTTTGCAAATACGGTNTGGAACAGGCGAGTG 43 E207D AATATCGACTTTAGTCATCCAGATGTACAAGATGAGTTGAAGGA 44 F272S GACGTAGGTGCTCTCGAATCTTATTTAGATGAAATGAATTGGG 45 S375P CGATAACATTCCAGCTAAAAA 46 W434R GACCTGGTGGTTCCAAGAGAATGTATGTAGGACGTCAT 47 E446D AATGGCGATGGATGGGGCGATTTCTTTACGAATGGAGGATCT 48 D128X CCAACGAATCGTTGGCAGNNNATTTCAGGTGCCTACACG 49 QEYK GTTGACTGGGATGAGCGCAAACAAGAAAATCAT 50 N190F TGGATGAAGAGTTCGGTAATTATGA 51 Q209 AGTCATCCAGAGGTCGTAGATGAGTTGAAGGAT
The “N” in the base sequence means a mixed base of A, T, G and C, while “Y” means a mixed base of T and C.
- By inserting an expression promoter region and the mutant α-amylase gene portion into the SmaI site of pKF19k again in a similar manner as the above, the mutation-introduced gene became a template plasmid upon introduction of another mutation. Another mutation was thus introduced in a similar manner to the above-described method.
- With these mutated recombinant plasmids thus obtained as a template, PCR reaction was conducted using primers CLUBG (SEQ ID No. 9) and LADH (SEQ ID No. 6) or primers CLUBS (SEQ ID No. 9) and K38DH (SEQ ID No. 8) to amplify the mutated gene fragments. After they were cut with SalI, they were inserted into the site of SalI-SmaI site of an expression vector pHSP64, whereby various plasmids for producing mutant α-amylases were constructed (
FIG. 1 ). - The various plasmids for producing mutant α-amylases obtained in Example 2 were each introduced into the strain Bacillus subtilis ISW1214 (leuA metB5 hsdM1) in accordance with the protoplast method. The recombinant Bacillus subtilis thus obtained was cultivated at 30+ C. for 4 days in a liquid medium (corn steep liquor, 4%; tryptose, 1%; meet extract, 1%, monopotassium phosphate, O.1%, magnesium sulfate, 0.01%, maltose, 2%, calcium chloride, 0.1%, tetracycline, 15 μg/mL). The activity of each of the various mutant α-amylases was measured using the supernatant of the culture medium.
- Each of an enzyme having Pro86 of ΔRG substituted with Ser (which will hereinafter be abbreviated as “P18S/ΔRG”), an enzyme having Gln86 substituted with Glu (“Q86E/ΔRG”), an enzyme having Glu130 substituted with Val (“E130V/ΔRG”), an enzyme having Asn154 substituted with Asp (“N154D/ΔRG”), an enzyme having Arg171 substituted with Cys (“R171C/ΔRG”), an enzyme having Ala186 substituted with Val (“A186V/ΔRG”), an enzyme having Glu212 substituted with Asp (“E212D/ΔRG”), an enzyme having Val222 substituted with Glu (“V222E/ΔRG”), an enzyme having Tyr243 substituted with Cys (“Y243C/ΔRG”) , an enzyme having Pro260 substituted with Glu (“P260E/ΔRG”), an enzyme having Lys269 substituted with Gln (“K269E/ΔRG”), an enzyme having Glu276 substituted with His (“E276H/ΔRG”), an enzyme having Asn277 substituted with Ser (“N277S/ΔRG”), an enzyme having Arg310 substituted with Ala (“R310A/ΔRG”), an enzyme having Glu360 substituted with Gln (“E360Q/ΔRG”), an enzyme having Gln391 substituted with Glu (“Q391E/ΔRG”), an enzyme having Trp439 substituted with Arg (“W439R/ΔRG”), an enzyme having Lys444 substituted with Arg (“K444R/ΔRG”), an enzyme having Asn471 substituted with Asp (“N471D/ΔRG”), and an enzyme having Gly476 substituted with Asp (“G476D/ΔRG) was assayed for amylase productivity. As a control, ΔRG was employed. A relative value (%) of amylase productivity was determined from the amylase productivity of ΔRG set at 100%. The results are shown in Table 3.
TABLE 3 Relative amylase Enzyme productivity (%) ΔRG 100 P18S/ΔRG 277 Q86E/ΔRG 119 E130V/ΔRG 362 N154D/ΔRG 146 R171C/ΔRG 235 A186V/ΔRG 485 E212D/ΔRG 327 V222E/ΔRG 135 Y243C/ΔRG 350 P260E/ΔRG 142 K269Q/ΔRG 142 E276H/ΔRG 231 N277S/ΔRG 312 R310A/ΔRG 208 E360Q/ΔRG 162 Q391E/ΔRG 127 W439R/ΔRG 312 K444R/ΔRG 112 N471D/ΔRG 292 G476D/ΔRG 296 - Any one of the mutant enzymes exhibited higher amylase productivity than ΔRG, indicating that mutation heightened productivity of α-amylase in recombinant Bacillus subtilis.
- In particular, the productivity of each of E130V/ΔRG, A186V/ΔRG, E212D/ΔRG, Y243C/ΔRG, N277S/ΔRG and W439R/ΔRG was found to be at least 3 times greater than that of ΔRG and above all, A186V/ΔRG exhibited eminently high productivity of almost 5 times greater than that of ΔRG.
- In a similar manner to the methods described in Examples 1, 2 and 3, each of an enzyme having Pro18 of ΔRG/MT substituted with Thr (which will hereinafter be abbreviated as “P18T/ΔRG/MT”), an enzyme having Gln86 substituted with Glu (“Q86E/ΔRG/MT”), an enzyme having Glu130 substituted with Val (“E130V/ΔRG/MT”), an enzyme having Ala186 substituted with Asn (“A186N/ΔRG/MT”), an enzyme having Tyr243 substituted with Ser (“Y243S/ΔRG/MT”), an enzyme having Asn277 substituted with Phe (“N277F/ΔRG/MT), and an enzyme having Asn471 substituted with Glu (“N471E/ΔRG/MT”) was assayed for amylase productivity. As a control, ΔRG/MT was employed. The results are shown in Table 4.
TABLE 4 Relative amylase Enzyme productivity (%) ΔRG/MT 100 P18T/ΔRG/MT 200 Q86E/ΔRG/MT 144 E130V/ΔRG/MT 344 A186N/ΔRG/MT 344 Y243S/ΔRG/MT 189 N277F/ΔRG/MT 256 N471E/ΔRG/MT 211 - It was recognized that any one of the above-described mutant enzymes exhibited high amylase productivity compared with ΔRG/MT, and in particular, the productivity of each of E130V/ΔRG/MT and A186N/ΔRG/MT was at least 3 times greater than that of ΔRG/MT.
- In accordance with the methods employed in Examples 1, 2 and 3, each of an enzyme having Asp128 of K38AMY substituted with Val (which will hereinafter be abbreviated as “D128V”), an enzyme having Gly140 substituted with Ser (“G140S”), an enzyme having Ser144 substituted with Pro (“S144P”), an enzyme having Arg168 substituted with Gln (“R168Q”), an enzyme having Asn181 substituted with Val (“N181V”), an enzyme having Glu207 substituted with Asp (“E207D”), an enzyme having Phe272 substituted with Ser (“F272S”), an enzyme having Ser375 substituted with Pro (“S375P”), an enzyme having Trp434 substituted with Arg (“W434R”), and an enzyme having Glu466 substituted with Asp (“E466D”) was assayed for amylase productivity. As a control, K38AMY was employed. The results are shown in Table 5.
TABLE 5 Relative amylase Enzyme productivity (%) K38AMY 100 D128V 325 G140S 209 S144P 197 R168Q 264 N181V 207 E207D 109 F272S 175 S375P 115 W434R 124 E466D 212 - It was recognized that compared with the wild type K38AMY, any one of the mutant enzymes exhibited high amylase productivity and in particular, D128V exhibited high productivity at least 3 times greater than that of K38AMY.
- A mutant enzyme S144P/N181V (which will hereinafter be abbreviated as “SPNV”) having, among the mutants shown in Example 6, S144P and N181V in combination was assayed for amylase productivity in accordance with the method as described in Example 3. As a control, K38AMY, S144P and N181V were employed. The results are shown in Table 6.
TABLE 6 Relative amylase Enzyme productivity (%) K38AMY 100 S144P 197 N181V 207 SPNV 257 - As a result, as shown in Table 6, a further improvement in amylase productivity was brought about by combined use.
- In accordance with the methods as described in Examples 1, 2 and 3, each of an enzyme obtained by substituting Arg168 of the gene of a heat-resistance improved enzyme LA-K38AMY/NFQV with Gln (which will hereinafter be abbreviated as “R168Q/LA-K38AMY/NFQV”), an enzyme obtained by substituting Glu466 of the above-described gene with Asp (“E466D/LA-K38AMY/NFQV”), and an enzyme having double mutations of Example 6 introduced into the gene (“SPNV/LA-K38AMY/NFQV”) was assayed for amylase productivity. As a control, LA-K38AMY/NFQV was employed. The results are shown in Table 7.
TABLE 7 Relative amylase Enzyme productivity (%) LA-K38AMY/NFQV 100 R168Q/LA-K38AMY/NFQV 304 E466D/LA-K38AMY/NFQV 264 SPNV/LA-K38AMY/NFQV 154 - As a result, it was recognized that any one of the mutant enzymes obtained in this Example exhibited high amylase productivity at least about 1.5 times greater than that of LA-K38AMY/NFQV and in particular, R168Q/LA-K38AMY/NFQV exhibited about 3 times greater productivity.
- In accordance with the methods as described in Examples 1, 2 and 3, each of an enzyme obtained by substituting Asp128 of the gene of a heat-resistance improved enzyme LA-K38AMY/QEYK/NFQV with Val (which will hereinafter be abbreviated as “D128V/LA-K38AMY/QEYK/NFQV”) and an enzyme having double mutations of Example 6 introduced into the gene (“SPNV/LA-K38AMY/QEYK/NFQV”) was assayed for amylase productivity. As a control, LA-K38AMY/QEYK/NFQV was employed. The results are shown in Table 8.
TABLE 8 Relative amylase Enzyme productivity (%) LA-K38AMY/QEYK/NFQV 100 D128V/LA-K38AMY/QEYK/NFQV 602 SPNV/LA-K38AMY/QEYK/NFQV 427 - As a result, it was recognized that any one of the mutant enzymes obtained in this Example exhibited markedly high amylase productivity compared with LA-K38AMY/QEYK/NFQV and in particular, D128V/LA-K38AMY/QEYK/NFQV exhibited drastic increase (about 6 times) in productivity.
- Into D128V/LA-K38AMY/QEYK/NFQV which was recognized to show a drastic increase in productivity among the mutant enzymes shown in Example 9, a mutation for heightening oxidant resistance by substituting Met107 with Leu (this mutation will hereinafter be abbreviated as “M107L”) was introduced in accordance with the methods as described in Examples 1 and 2 (“ML/DV/LA-K38AMY/QEYK/NFQV”).
- Then, the gene of the mutant enzyme ML/DV/LA-K38AMY/QEYK/NFQV was assayed for amylase productivity in accordance with the method of Example 4. As a control, D128V/LA-K38AMY/QEYK/NFQV was employed. The results are shown in Table 9.
TABLE 9 Relative amylase Enzyme productivity (%) D128V/LA-K38AMY/QEYK/NFQV 100 M107L/D128V/LA- 115 K38AMY/QEYK/NFQV - The relative amylase productivity of the mutant enzyme ML/DV/LA-K38AMY/QEYK/NFQV was 115%, indicating that introduction of M107L mutation for reinforcing oxidant resistance did not adversely affect high productivity of amylase in recombinant Bacillus subtilis.
- In accordance with the methods as described in Examples 1, 2 and 3, an enzyme obtained by substituting Asp128 of the gene of heat-resistance-improved enzyme QEYK/NFQV with Gln (the resultant enzyme will hereinafter be abbreviated as “D128Q/QEYK/NFQV”) was assayed for amylase productivity. As a control, QEYK/NFQV was employed. The results are shown in Table 10.
TABLE 10 Relative amylase Enzyme productivity (%) QEYK/NFQV 100 D128Q/QEYK/NFQV 247 - It was recognized that the mutant enzyme exhibited productivity of at least 2 times greater than that of QEYK/NFQV.
- After storage of each of the mutant enzyme preparations as shown in Table 11 at 4° C. for 1 week, the precipitate formed by centrifugation (13000 rpm, 10 minutes, 4° C.) was separated. The precipitate was suspended in the same volume, as that before centrifugation, of a Tris-HCl buffer (pH 7.0) containing of 2 MM CaCl2. The resulting suspension was diluted about 500-folds with the same buffer to dissolve the former in the latter and enzymatic activity in the resulting solution was measured. The supernatant was diluted in a similar manner and enzymatic activity in it was also measured. Solubility of each of the mutant enzymes was evaluated by comparing the enzymatic activity in each of the precipitate solution and supernatant with that of the preparation before storage at 4° C. The results are shown collectively in Table 11.
TABLE 11 Residual activity (%) after storage at 4° C. Enzyme Supernatant Precipitate ΔRG 55 40 ΔRG Gln86 → Glu 83 11 ΔRG Pro260 → Glu 70 18 ΔRG Lys269 → Gln 74 27 ΔRG Asn471 → Asp 74 23 ΔRG Lys484 → Gln 71 24 - As a result, when an improved α-amylase (ΔRG) having heat resistance improved by deleting Arg181 and Gly182 was stored at 4° C. for one week, precipitation of the enzyme was recognized and only about half of the activity remained in the supernatant. On the other hand, the mutant enzymes obtained by introducing a further mutation in ΔRG-LAMY showed a high activity residual ratio in the supernatant, indicating an improvement in solubility by mutation. In particular, the enzyme having Gln86 substituted with Glu showed the highest enzyme solubility and 80% of the enzyme remained in the supernatant under the conditions of this Example.
- A detergent composition for automatic dish washer having the composition as shown in Table 12 was prepared, followed by incorporation therein of various mutant enzymes obtained in the productivity increasing method. As a result, the highly productive mutant enzymes exhibited similar or superior detergency to the control enzyme when they were equal in activity.
TABLE 12 Composition of detergent (%) Pluronic L-61 2.2 Sodium carbonate 24.7 Sodium bicarbonate 24.7 Sodium percarbonate 10.0 No. 1 sodium silicate 12.0 Trisodium citrate 20.0 Polypropylene glycol 2.2 “Silicone KST-04” (product of Toshiba Silicone) 0.1 “Sokalan CP-45” (product of BASF) 4.0
Capability of Exploitation Industry - By using the mutant α-amylases according to the present invention, α-amylases are available at a high yield from recombinant microorganisms, making it possible to largely reduce the cost of their industrial production. The mutation for productivity increase in the present invention does not adversely affect biochemical properties of the enzymes so that highly productive liquefying alkaline α-amylases having heat resistance, chelating agent resistance and oxidant resistance and being useful as enzymes for a detergent can be produced.
Claims (8)
1. A mutant α-amylase which is derived from an α-amylase having an amino acid sequence represented by SEQ ID No. 2 or showing at least 60% homology thereto by substitution or deletion of at least one amino acid residue corresponding to any one of Pro18, Gln86, Glu130, Asn154, Arg171, Ala186, Glu212, Val222, Tyr243, Pro260, Lys269, Glu276, Asn277, Arg310, Glu360, Gln391, Trp439, Lys444, Asn471 and Gly476 of the amino acid sequence.
2. (canceled)
3. A mutant α-amylase according to claim 1 , wherein the substitution or deletion of at least one amino acid residue is substitution of the amino acid residue corresponding to Pro18 with Ser or Thr, the amino acid residue corresponding to Gln86 with Glu, the amino acid residue corresponding to Glu130 with Val or Gln, the amino acid residue corresponding to Asn154 with Asp, the amino acid residue corresponding to Arg171 with Cys or Gln, the amino acid residue corresponding to Ala186 with Val or Asn, the amino acid residue corresponding to Glu212 with Asp, the amino acid residue corresponding to Val222 with Glu, the amino acid residue corresponding to Tyr243 with Cys or Ser, the amino acid residue corresponding to Pro260 with Glu, the amino acid residue corresponding to Lys269 with Gln, the amino acid residue corresponding to Glu276 with His, the amino acid residue corresponding to Asn277 with Ser or Phe, the amino acid residue corresponding to Arg310 with Ala, the amino acid residue corresponding to Glu360 with Gln, the amino acid residue corresponding to Gln391 with Glu, the amino acid residue corresponding to Trp439 with Arg, the amino acid residue corresponding to Lys444 with Arg, the amino acid residue corresponding to Asn471 with Asp or Glu, or the amino acid residue corresponding to Gly476 with Asp.
4. (canceled)
5. A gene encoding a mutant α-amylase as claimed in claim 1 , or a vector containing said gene.
6. A cell transformed by a vector as claimed in claim 5 .
7. A method for producing a mutant α-amylase, which comprises cultivating a transformant cell as claimed in claim 6 .
8. A detergent composition comprising a mutant α-amylase as claimed in claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/590,769 US20080026976A1 (en) | 2000-10-11 | 2006-11-01 | Highly productive alpha-amylases |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000310605A JP4426716B2 (en) | 2000-10-11 | 2000-10-11 | High productivity α-amylase |
JP2000-310605 | 2000-10-11 | ||
US09/971,611 US6743616B2 (en) | 2000-10-11 | 2001-10-09 | Highly productive alpha-amylases |
US10/798,278 US7297527B2 (en) | 2000-10-11 | 2004-03-12 | Highly productive α-amylases |
US11/590,769 US20080026976A1 (en) | 2000-10-11 | 2006-11-01 | Highly productive alpha-amylases |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/798,278 Division US7297527B2 (en) | 2000-10-11 | 2004-03-12 | Highly productive α-amylases |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080026976A1 true US20080026976A1 (en) | 2008-01-31 |
Family
ID=18790534
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/971,611 Expired - Fee Related US6743616B2 (en) | 2000-10-11 | 2001-10-09 | Highly productive alpha-amylases |
US10/798,278 Expired - Fee Related US7297527B2 (en) | 2000-10-11 | 2004-03-12 | Highly productive α-amylases |
US11/590,769 Abandoned US20080026976A1 (en) | 2000-10-11 | 2006-11-01 | Highly productive alpha-amylases |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/971,611 Expired - Fee Related US6743616B2 (en) | 2000-10-11 | 2001-10-09 | Highly productive alpha-amylases |
US10/798,278 Expired - Fee Related US7297527B2 (en) | 2000-10-11 | 2004-03-12 | Highly productive α-amylases |
Country Status (6)
Country | Link |
---|---|
US (3) | US6743616B2 (en) |
EP (1) | EP1199356B2 (en) |
JP (1) | JP4426716B2 (en) |
CN (1) | CN100415878C (en) |
DE (1) | DE60139238D1 (en) |
DK (1) | DK1199356T4 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69534464T2 (en) * | 1994-03-29 | 2006-09-28 | Novozymes A/S | ALKALIC AMYLASE FROM BACELLUS |
CN100482790C (en) * | 2000-03-08 | 2009-04-29 | 诺维信公司 | Variants with altered properties |
EP1307547B1 (en) | 2000-07-28 | 2005-10-26 | Henkel Kommanditgesellschaft auf Aktien | Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
EP1340805A4 (en) * | 2000-12-05 | 2004-05-12 | Miz Co Ltd | Method of laundering clothes and detergent composition therefor |
AU2002254876A1 (en) * | 2001-05-15 | 2002-11-25 | Novozymes A/S | Alpha-amylase variant with altered properties |
JP4346368B2 (en) * | 2002-08-02 | 2009-10-21 | 花王株式会社 | Recombinant Bacillus subtilis |
DE102004047776B4 (en) * | 2004-10-01 | 2018-05-09 | Basf Se | Stabilized against di- and / or multimerization alpha-amylase variants, processes for their preparation and their use |
CN100396777C (en) * | 2005-10-28 | 2008-06-25 | 南开大学 | A thermophilic alkaline α-amylase and its coding gene |
CN101668855B (en) | 2007-03-23 | 2013-07-03 | 丹尼斯科美国公司 | Enhanced amylase production by n-terminal addition to mature amylase protein |
EP2215202B2 (en) | 2007-11-05 | 2024-01-10 | Danisco US Inc. | VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
AU2008325249B2 (en) | 2007-11-05 | 2013-10-10 | Danisco Us Inc. | Alpha-amylase variants with altered properties |
AU2009212526A1 (en) | 2008-02-04 | 2009-08-13 | Danisco Us Inc. | TS23 alpha-amylase variants with altered properties |
AU2009256280B2 (en) * | 2008-06-06 | 2013-03-07 | Danisco Us Inc. | Geobacillus stearothermophilus alpha-amylase (AmyS) variants with improved properties |
CN102224234B (en) | 2008-09-25 | 2014-04-16 | 丹尼斯科美国公司 | Alpha-amylase blends and methods for using said blends |
BRPI1010238A2 (en) | 2009-04-01 | 2015-08-25 | Danisco Us Inc | Compositions and methods comprising alpha-amylase variants with altered properties |
JP5735775B2 (en) | 2009-10-21 | 2015-06-17 | 花王株式会社 | Modified promoter |
CN102918149A (en) | 2010-01-04 | 2013-02-06 | 诺维信公司 | Alpha-amylases |
EP2357220A1 (en) | 2010-02-10 | 2011-08-17 | The Procter & Gamble Company | Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent |
PL3543333T3 (en) * | 2011-06-30 | 2022-06-13 | Novozymes A/S | Method for screening alpha-amylases |
EP2540824A1 (en) | 2011-06-30 | 2013-01-02 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants reference to a sequence listing |
EP3798303A1 (en) | 2011-06-30 | 2021-03-31 | Novozymes A/S | Alpha-amylase-variants |
RU2019123965A (en) | 2017-02-01 | 2021-02-01 | Дзе Проктер Энд Гэмбл Компани | CLEANING COMPOSITIONS CONTAINING AMYLASE VERSIONS |
WO2020188095A1 (en) * | 2019-03-21 | 2020-09-24 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1062906C (en) | 1993-05-19 | 2001-03-07 | 花王株式会社 | Liquefying alkaline alpha-amylase, process for producing the same, and detergent composition containing the same |
AR000862A1 (en) | 1995-02-03 | 1997-08-06 | Novozymes As | VARIANTS OF A MOTHER-AMYLASE, A METHOD TO PRODUCE THE SAME, A DNA STRUCTURE AND A VECTOR OF EXPRESSION, A CELL TRANSFORMED BY SUCH A DNA STRUCTURE AND VECTOR, A DETERGENT ADDITIVE, DETERGENT COMPOSITION, A COMPOSITION FOR AND A COMPOSITION FOR THE ELIMINATION OF |
AU4483496A (en) | 1995-02-03 | 1996-08-21 | Novo Nordisk A/S | A method of designing alpha-amylase mutants with predetermined properties |
EP0904360B1 (en) * | 1996-04-30 | 2013-07-31 | Novozymes A/S | alpha-AMYLASE MUTANTS |
BR9612702A (en) | 1996-08-01 | 1999-08-03 | Procter & Gamble | Detergent composition comprising amylase optimized for cleaning dingy fabrics |
US6486113B1 (en) | 1997-03-31 | 2002-11-26 | Kao Corporation | Mutant α-amylases |
CN1163597C (en) * | 1997-10-30 | 2004-08-25 | 诺维信公司 | α-amylase mutant |
JP3541697B2 (en) * | 1998-11-20 | 2004-07-14 | ソニーケミカル株式会社 | Manufacturing method of flexible wiring board |
JP4077095B2 (en) | 1998-12-21 | 2008-04-16 | 花王株式会社 | New amylase |
JP2000184883A (en) | 1998-12-21 | 2000-07-04 | Kao Corp | New amylase |
US6410295B1 (en) * | 1999-03-30 | 2002-06-25 | Novozymes A/S | Alpha-amylase variants |
US6309871B1 (en) * | 1999-03-31 | 2001-10-30 | Novozymes A/S | Polypeptides having alkaline α-amylase activity |
WO2000060058A2 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
JP4417532B2 (en) | 1999-06-10 | 2010-02-17 | 花王株式会社 | Mutant α-amylase |
CN100523182C (en) | 1999-06-10 | 2009-08-05 | 花王株式会社 | Mutant alpha-amylase |
-
2000
- 2000-10-11 JP JP2000310605A patent/JP4426716B2/en not_active Expired - Fee Related
-
2001
- 2001-10-09 US US09/971,611 patent/US6743616B2/en not_active Expired - Fee Related
- 2001-10-10 EP EP01123378.0A patent/EP1199356B2/en not_active Expired - Lifetime
- 2001-10-10 DE DE60139238T patent/DE60139238D1/en not_active Expired - Lifetime
- 2001-10-10 DK DK01123378.0T patent/DK1199356T4/en active
- 2001-10-11 CN CNB011412534A patent/CN100415878C/en not_active Expired - Fee Related
-
2004
- 2004-03-12 US US10/798,278 patent/US7297527B2/en not_active Expired - Fee Related
-
2006
- 2006-11-01 US US11/590,769 patent/US20080026976A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1199356A2 (en) | 2002-04-24 |
CN100415878C (en) | 2008-09-03 |
DK1199356T4 (en) | 2014-02-17 |
CN1348000A (en) | 2002-05-08 |
EP1199356A3 (en) | 2002-05-15 |
DE60139238D1 (en) | 2009-08-27 |
US7297527B2 (en) | 2007-11-20 |
US6743616B2 (en) | 2004-06-01 |
JP2002112792A (en) | 2002-04-16 |
US20040265959A1 (en) | 2004-12-30 |
EP1199356B2 (en) | 2014-01-22 |
JP4426716B2 (en) | 2010-03-03 |
EP1199356B1 (en) | 2009-07-15 |
US20020123124A1 (en) | 2002-09-05 |
DK1199356T3 (en) | 2009-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080026976A1 (en) | Highly productive alpha-amylases | |
EP0867504B1 (en) | Oxidation-stable alpha-amylase | |
AU686007B2 (en) | An improved cleaning composition | |
US6403355B1 (en) | Amylases | |
JP4253041B2 (en) | Protein with improved stability | |
US20090226961A1 (en) | Mutant alpha-amylases | |
JPH11502562A (en) | Improved laundry detergent compositions containing amylase | |
EP0985731B1 (en) | Mutated alpha-amylases | |
JP4417532B2 (en) | Mutant α-amylase | |
NZ524303A (en) | Alpha amylase enzymes with increased stability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |